ATE202106T1 - Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge - Google Patents

Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge

Info

Publication number
ATE202106T1
ATE202106T1 AT91115485T AT91115485T ATE202106T1 AT E202106 T1 ATE202106 T1 AT E202106T1 AT 91115485 T AT91115485 T AT 91115485T AT 91115485 T AT91115485 T AT 91115485T AT E202106 T1 ATE202106 T1 AT E202106T1
Authority
AT
Austria
Prior art keywords
immunosupressants
adenosine analogues
analogues useful
carbocyclic adenosine
new carbocyclic
Prior art date
Application number
AT91115485T
Other languages
English (en)
Inventor
David R Borcherding
Iii Carl K Edwards
Ronald E Esser
Douglas L Cole
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE202106T1 publication Critical patent/ATE202106T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT91115485T 1990-09-14 1991-09-12 Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge ATE202106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58228090A 1990-09-14 1990-09-14
US74817291A 1991-08-23 1991-08-23

Publications (1)

Publication Number Publication Date
ATE202106T1 true ATE202106T1 (de) 2001-06-15

Family

ID=27078528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91115485T ATE202106T1 (de) 1990-09-14 1991-09-12 Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge

Country Status (19)

Country Link
EP (1) EP0475411B1 (de)
JP (1) JP3099280B2 (de)
KR (1) KR100249111B1 (de)
CN (1) CN1031132C (de)
AR (1) AR247566A1 (de)
AT (1) ATE202106T1 (de)
AU (1) AU647822B2 (de)
CA (1) CA2051012C (de)
DE (1) DE69132632T2 (de)
DK (1) DK0475411T3 (de)
ES (1) ES2158840T3 (de)
FI (1) FI102755B1 (de)
GR (1) GR3036577T3 (de)
HU (1) HU209304B (de)
IE (1) IE913247A1 (de)
IL (1) IL99466A (de)
NO (1) NO179908C (de)
NZ (1) NZ239750A (de)
PT (1) PT98943B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642526B2 (en) * 1990-09-14 1993-10-21 Marion Merrell Dow Inc. Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
US5470857A (en) * 1990-09-14 1995-11-28 Marion Merrell Dow Inc. Carbocyclic nucleoside analogs useful as immunosuppressants
US5817661A (en) 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
CA2084222C (en) * 1991-12-06 2004-04-06 David R. Borcherding Novel trans cyclopentanyl purine analogs useful as immunosuppressants
US5723466A (en) * 1991-12-06 1998-03-03 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817660A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
US6765008B1 (en) * 1992-12-17 2004-07-20 Pfizer Inc Pyrrolopyrimidines as CRF antagonists
DE69402548T2 (de) * 1993-06-21 1997-07-17 Merrell Pharma Inc Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen
HUT74989A (en) * 1993-11-12 1997-03-28 Merrell Pharma Inc 6-oxo-nucleosides useful as immunosuppressants
TW282470B (de) * 1993-11-18 1996-08-01 Ajinomoto Kk
EP0682027B1 (de) * 1994-05-03 1997-10-15 Novartis AG Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
KR20020063934A (ko) 2000-01-18 2002-08-07 화이자 프로덕츠 인코포레이티드 코르티코트로핀 방출 인자 길항제
EP1661897B1 (de) * 2003-08-26 2013-12-04 Teijin Pharma Limited Pyrrolopyrimidinonderivat
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551428A (en) * 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
US3917837A (en) * 1974-10-21 1975-11-04 American Cyanamid Co Method of using trans-2-(6-amino-9H-purin-9-yl)-cyclopentanol
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4386093A (en) * 1981-09-16 1983-05-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services (±)3-Deazaaristeromycin and uses
IN164556B (de) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4859677A (en) * 1987-04-17 1989-08-22 University Of Kansas Nucleoside analogues having antiviral activity
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
IL86381A0 (en) * 1987-05-19 1988-11-15 Nippon Kayaku Kk Oxetanocins and pharmaceutical compositions containing the same
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds

Also Published As

Publication number Publication date
FI914319L (fi) 1992-03-15
HU912961D0 (en) 1992-01-28
CN1059909A (zh) 1992-04-01
JP3099280B2 (ja) 2000-10-16
EP0475411A1 (de) 1992-03-18
FI914319A0 (fi) 1991-09-13
JPH04270282A (ja) 1992-09-25
ES2158840T3 (es) 2001-09-16
PT98943B (pt) 1999-02-26
IE913247A1 (en) 1992-02-25
EP0475411B1 (de) 2001-06-13
NO913625D0 (no) 1991-09-13
IL99466A0 (en) 1992-08-18
FI102755B (fi) 1999-02-15
AR247566A1 (es) 1995-01-31
NO913625L (no) 1992-03-16
PT98943A (pt) 1992-07-31
KR100249111B1 (ko) 2000-08-01
AU8372991A (en) 1992-03-19
GR3036577T3 (en) 2001-12-31
HUT59138A (en) 1992-04-28
DE69132632D1 (de) 2001-07-19
CA2051012C (en) 2002-04-02
AU647822B2 (en) 1994-03-31
NZ239750A (en) 1994-02-25
HU209304B (en) 1994-04-28
CN1031132C (zh) 1996-02-28
DK0475411T3 (da) 2001-10-01
NO179908B (no) 1996-09-30
CA2051012A1 (en) 1992-03-15
NO179908C (no) 1997-01-08
IL99466A (en) 1996-07-23
DE69132632T2 (de) 2002-04-18
FI102755B1 (fi) 1999-02-15
KR920006357A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
ATE202106T1 (de) Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge
FI935373A0 (fi) Kopplingsstycke eller koppling foer ledning
DE69310214D1 (de) Dialogsystem
DE69325333D1 (de) Antivirale Zusammensetzung
FI924299L (fi) Dambinda eller inkontinensskydd
FI931172L (fi) Vatten- och/eller oljeogenomslaepplig taetningsmatta
FI930841A7 (fi) Kombinerad kontroll- och reglerventil foer vaetskor eller gaser
FI933713L (fi) Taeppande eller taetande akrylkomposition
FI933421L (fi) Flerskiktsinloppslaoda foer en pappersmaskin eller dylik
FI925957A0 (fi) Styranordning foer en eller flera arbetspunkter
FI925930L (fi) En kosmetisk eller dermatologisk blandning innehaollande en diolester
FI932970A0 (fi) Betongtransportblandare eller liknande
FI935253L (fi) Granatkastare foersedd med en eller flera eldroer
DE69331227D1 (de) Radiergummi
FI922855L (fi) Laett foerslutningsbar paose eller saeck
KR950703757A (ko) 양성-작용 포토레지스트 조성물(posivive-working pothoresist composition)
FI961105A7 (fi) Difluoristatoniviruksen vastaisia analogeja
FI960051L (fi) Difluoristatonianalogeja
KR910008699U (ko) 보조 정수기
KR940014625U (ko) 전침기
FR2646165B3 (fr) Peinture
FI931379A0 (fi) Foerbaettringar i eller i samband med mobilradiokommunikationssystem
FI980U1 (fi) Ledstaong eller handtag
FI450U1 (fi) Saekringssockel eller radsaekring
FI496U1 (fi) Skyddskaopa foer broedlaoda eller liknande

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee